427 related articles for article (PubMed ID: 19149981)
1. Treatment outcome of acne vulgaris with oral isotretinoin.
Bener A; Lestringant GG; Ehlayel MS; Saarinen K; Takiddin AH
J Coll Physicians Surg Pak; 2009 Jan; 19(1):49-51. PubMed ID: 19149981
[TBL] [Abstract][Full Text] [Related]
2. Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol.
Lestringant GG; Frossard PM; Agarwal M; Galadari IH
Int J Dermatol; 1997 Nov; 36(11):859-62. PubMed ID: 9427082
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
4. Effect of isotretinoin treatment on plasma holotranscobalamin, vitamin B12, folic acid, and homocysteine levels: non-controlled study.
Karadag AS; Tutal E; Ertugrul DT; Akin KO
Int J Dermatol; 2011 Dec; 50(12):1564-9. PubMed ID: 22098008
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin does not prolong QT intervals and QT dispersion in patients with severe acne: a surprising finding for a drug with numerous side effects.
Dursun R; Alpaslan M; Caliskan M; Ciftci O; Kulaksizoglu S; Seckin D; Muderrisoglu H
J Drugs Dermatol; 2011 Jul; 10(7):710-4. PubMed ID: 21720652
[TBL] [Abstract][Full Text] [Related]
6. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
[TBL] [Abstract][Full Text] [Related]
7. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
Erturan İ; Naziroğlu M; Akkaya VB
Cell Biochem Funct; 2012 Oct; 30(7):552-7. PubMed ID: 22517509
[TBL] [Abstract][Full Text] [Related]
8. Isotretinoin's Effect on Fasting Lipid Profile in Acne Patients.
Sajid M; Asim SA; Iqbal T; Bhatti S; Zahir A; Imtiaz S
J Coll Physicians Surg Pak; 2024 May; 34(5):518-521. PubMed ID: 38720209
[TBL] [Abstract][Full Text] [Related]
9. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
10. Creatine phosphokinase values during isotretinoin treatment for acne.
Kaymak Y
Int J Dermatol; 2008 Apr; 47(4):398-401. PubMed ID: 18377609
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
Bershad S; Rubinstein A; Paterniti JR; Le NA; Poliak SC; Heller B; Ginsberg HN; Fleischmajer R; Brown WV
N Engl J Med; 1985 Oct; 313(16):981-5. PubMed ID: 2931603
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. A prospective study.
Zech LA; Gross EG; Peck GL; Brewer HB
Arch Dermatol; 1983 Dec; 119(12):987-93. PubMed ID: 6228196
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral isotretinoin on serum folic acid levels.
Javanbakht AM; Pour HM; Tarrahic MJ
J Drugs Dermatol; 2012 Sep; 11(9):e23-4. PubMed ID: 23135667
[TBL] [Abstract][Full Text] [Related]
15. Oral isotretinoin therapy of acne patients decreases serum paraoxonase-1 activity through increasing oxidative stress.
Ozkol HU; Ozkol H; Karadag AS; Bilgili SG; Tuluce Y; Calka O
Drug Chem Toxicol; 2015 Jan; 38(1):63-6. PubMed ID: 24697846
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
[TBL] [Abstract][Full Text] [Related]
17. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
[TBL] [Abstract][Full Text] [Related]
18. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
19. Effects of isotretinoin therapy on lipoprotein (a) serum levels.
Georgala S; Schulpis KH; Potouridou I; Papadogeorgaki H
Int J Dermatol; 1997 Nov; 36(11):863-4. PubMed ID: 9427083
[TBL] [Abstract][Full Text] [Related]
20. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
Zane LT; Leyden WA; Marqueling AL; Manos MM
Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
